Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses

Official record

Identifier

NCT07631598

Recruiting locations

country

United States

Interventions studied

Standard of Care ReferralLow Threshold Buprenorphine

Lead sponsor

Montefiore Medical Center

Target enrolment

512 participants

Study type

INTERVENTIONAL

Phase

Not applicable

Status

Recruiting

First posted

Jun 8, 2026

Last updated on the registry

Oct 1, 2026

Age

18 Years

Sex

ALL

Study contact

The official record lists a study contact. Contact details are published there and are intentionally not copied to this page.

Eligibility criteria

Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.

Inclusion Criteria:

1. ≥ 18 years old;
2. Meet DSM-5 criteria for moderate or severe OUD;
3. Interest in receiving buprenorphine treatment;
4. Speaks English or Spanish;
5. Currently an SSP client at the time of enrollment;
6. Ability to provide informed consent.

Exclusion Criteria:

1. Current use of prescribed opioid agonist treatment, as assessed by self-report, at the time of enrollment;
2. Unstable mental health or medical condition that requires an immediate clinical evaluation or higher level of care;
3. Allergy to buprenorphine;
4. Currently detained in jail, prison, residential substance use treatment facility, or other overnight facility as required by court of law. or have pending legal action that could prevent participation on study activities.

Indexed under

Lymphoma